3-bromo-5-(oxetan-3-yl)pyridine;(5-bromo-3-pyridinyl)boronic acid;6-[5-(oxetan-3-yl)-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide

C45H53B2Br2N9O8 — CID 158345215

IUPAC3-bromo-5-(oxetan-3-yl)pyridine;(5-bromo-3-pyridinyl)boronic acid;6-[5-(oxetan-3-yl)-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide
SMILESBrc1cncc(C2COC2)c1.CC1(C)OB(c2cnc3c(c2)CCCN3C(N)=O)OC1(C)C.NC(=O)N1CCCc2cc(-c3cncc(C4COC4)c3)cnc21.OB(O)c1cncc(Br)c1
InChIInChI=1S/C17H18N4O2.C15H22BN3O3.C8H8BrNO.C5H5BBrNO2/c18-17(22)21-3-1-2-11-4-14(8-20-16(11)21)12-5-13(7-19-6-12)15-9-23-10-15;1-14(2)15(3,4)22-16(21-14)11-8-10-6-5-7-19(13(17)20)12(10)18-9-11;9-8-1-6(2-10-3-8)7-4-11-5-7;7-5-1-4(6(9)10)2-8-3-5/h4-8,15H,1-3,9-10H2,(H2,18,22);8-9H,5-7H2,1-4H3,(H2,17,20);1-3,7H,4-5H2;1-3,9-10H
InChIKeyGRQMPJCLXGDLRI-UHFFFAOYSA-N
MW1029.41 g/mol
LogP4.78
Rot. Bonds5

About 3-bromo-5-(oxetan-3-yl)pyridine;(5-bromo-3-pyridinyl)boronic acid;6-[5-(oxetan-3-yl)-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide

3-bromo-5-(oxetan-3-yl)pyridine;(5-bromo-3-pyridinyl)boronic acid;6-[5-(oxetan-3-yl)-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide (PubChem CID 158345215) has the molecular formula C45H53B2Br2N9O8 and a molecular weight of 1029.41 g/mol. Its IUPAC name is 3-bromo-5-(oxetan-3-yl)pyridine;(5-bromo-3-pyridinyl)boronic acid;6-[5-(oxetan-3-yl)-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide.

Molecular Properties

Compound Name3-bromo-5-(oxetan-3-yl)pyridine;(5-bromo-3-pyridinyl)boronic acid;6-[5-(oxetan-3-yl)-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide
PubChem CID158345215
Molecular FormulaC45H53B2Br2N9O8
Molecular Weight1029.41 g/mol
Exact Mass1027.26
IUPAC Name3-bromo-5-(oxetan-3-yl)pyridine;(5-bromo-3-pyridinyl)boronic acid;6-[5-(oxetan-3-yl)-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide
SMILESBrc1cncc(C2COC2)c1.CC1(C)OB(c2cnc3c(c2)CCCN3C(N)=O)OC1(C)C.NC(=O)N1CCCc2cc(-c3cncc(C4COC4)c3)cnc21.OB(O)c1cncc(Br)c1
InChIInChI=1S/C17H18N4O2.C15H22BN3O3.C8H8BrNO.C5H5BBrNO2/c18-17(22)21-3-1-2-11-4-14(8-20-16(11)21)12-5-13(7-19-6-12)15-9-23-10-15;1-14(2)15(3,4)22-16(21-14)11-8-10-6-5-7-19(13(17)20)12(10)18-9-11;9-8-1-6(2-10-3-8)7-4-11-5-7;7-5-1-4(6(9)10)2-8-3-5/h4-8,15H,1-3,9-10H2,(H2,18,22);8-9H,5-7H2,1-4H3,(H2,17,20);1-3,7H,4-5H2;1-3,9-10H
InChIKeyGRQMPJCLXGDLRI-UHFFFAOYSA-N
XLogP4.78
TPSA234.49 Ų
H-Bond Donors4
H-Bond Acceptors13
Rotatable Bonds5
Heavy Atoms66
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 5001029.41
LogP ≤ 54.78
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1013

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze 3-bromo-5-(oxetan-3-yl)pyridine;(5-bromo-3-pyridinyl)boronic acid;6-[5-(oxetan-3-yl)-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-bromo-5-(oxetan-3-yl)pyridine;(5-bromo-3-pyridinyl)boronic acid;6-[5-(oxetan-3-yl)-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide?
The IUPAC name of 3-bromo-5-(oxetan-3-yl)pyridine;(5-bromo-3-pyridinyl)boronic acid;6-[5-(oxetan-3-yl)-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide (CID 158345215) is 3-bromo-5-(oxetan-3-yl)pyridine;(5-bromo-3-pyridinyl)boronic acid;6-[5-(oxetan-3-yl)-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide.
What is the SMILES notation for 3-bromo-5-(oxetan-3-yl)pyridine;(5-bromo-3-pyridinyl)boronic acid;6-[5-(oxetan-3-yl)-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide?
The canonical SMILES for 3-bromo-5-(oxetan-3-yl)pyridine;(5-bromo-3-pyridinyl)boronic acid;6-[5-(oxetan-3-yl)-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide is Brc1cncc(C2COC2)c1.CC1(C)OB(c2cnc3c(c2)CCCN3C(N)=O)OC1(C)C.NC(=O)N1CCCc2cc(-c3cncc(C4COC4)c3)cnc21.OB(O)c1cncc(Br)c1.
What is the InChIKey of 3-bromo-5-(oxetan-3-yl)pyridine;(5-bromo-3-pyridinyl)boronic acid;6-[5-(oxetan-3-yl)-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide?
The InChIKey is GRQMPJCLXGDLRI-UHFFFAOYSA-N. The full InChI is InChI=1S/C17H18N4O2.C15H22BN3O3.C8H8BrNO.C5H5BBrNO2/c18-17(22)21-3-1-2-11-4-14(8-20-16(11)21)12-5-13(7-19-6-12)15-9-23-10-15;1-14(2)15(3,4)22-16(21-14)11-8-10-6-5-7-19(13(17)20)12(10)18-9-11;9-8-1-6(2-10-3-8)7-4-11-5-7;7-5-1-4(6(9)10)2-8-3-5/h4-8,15H,1-3,9-10H2,(H2,18,22);8-9H,5-7H2,1-4H3,(H2,17,20);1-3,7H,4-5H2;1-3,9-10H.
What are the key properties of 3-bromo-5-(oxetan-3-yl)pyridine;(5-bromo-3-pyridinyl)boronic acid;6-[5-(oxetan-3-yl)-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide?
3-bromo-5-(oxetan-3-yl)pyridine;(5-bromo-3-pyridinyl)boronic acid;6-[5-(oxetan-3-yl)-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide has a molecular weight of 1029.41 g/mol, XLogP of 4.78, 5 rotatable bonds, 4 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for 3-bromo-5-(oxetan-3-yl)pyridine;(5-bromo-3-pyridinyl)boronic acid;6-[5-(oxetan-3-yl)-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide is sourced from PubChem (CID 158345215), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).